De Novo device
vPATCH
Virility Medical , Ltd. · Non-Implanted Electrical Stimulation Device For Management Of Premature Ejaculation (QRC, Class II) · First FDA decision Nov 23, 2021, newest May 1, 2023Erectile dysfunction
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
De Novo pathway
Device trials
1
Naming "vPATCH"
MAUDE reports
3
Brand "vPATCH", since 2015
PubMed studies
7
Mentioning "vPATCH"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing vPATCH
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- vPATCH510(k)
K223595 · Decided May 1, 2023 · 150 days after receipt
Device type: Non-Implanted Electrical Stimulation Device For Management Of Premature Ejaculation (QRC) · GI, Urology & Nephrology
- vPatchNew device typeDe Novo
DEN210012 · Decided Nov 23, 2021 · 238 days after receipt
Device type: Non-Implanted Electrical Stimulation Device For Management Of Premature Ejaculation (QRC) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Transcutaneous Electrical Nerve Stimulation for Chronic Low Back PainNational analysisReview closedCAG-00429NUpdated Sep 24, 2026
- Cavernous Nerves Electrical Stimulation with Penile PlethysmographyNational analysisReview closedCAG-00311NUpdated Sep 17, 2026
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Neuromuscular Electrical Stimulation (NMES) for Spinal Cord InjuryNational analysisReview closedCAG-00153RUpdated Sep 15, 2026
- Electrical Stimulation for Fracture HealingNational analysisReview closedCAG-00043NUpdated Sep 14, 2026
- Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back Pain (CLBP)National determinationOn the books160.27Updated Feb 10, 2026
- Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative PainNational determinationOn the books10.2Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "vPATCH", any status and sponsor, newest update first.
Virility Medical Ltd.Not on our public-company list
NCT03942367 · 59 participants · Start Sep 10, 2019 · Primary completion Jul 15, 2020
Device: Active Device (vPatch); Sham Device (vPatch) · For: Premature Ejaculation
Sites: Haifa, Israel; Sesto Fiorentino, Italy; Naples, Italy
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "vPATCH", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code QRC
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- ATRIUM C-QUR VPATCH MESHInjury
MW5085448 · Received Mar 29, 2019 · Event dated Dec 5, 2018
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Itching Sensation; Pain; Swelling
- C-QUR VPATCHInjury
3011175548-2018-00665 · Received Jun 27, 2018
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pain; Hernia
- C-QUR VPATCHInjury
3011175548-2018-00314 · Received Apr 6, 2018
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abdominal Pain
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "vPATCH"[tiab]. The summary above synthesizes these.
- Commentary: One-patch, two-patch, V-patch?
Backer CL · J Thorac Cardiovasc Surg · 2023Editorial, Comment
- Trends, safety, and efficacy of wearable male sexual devices.
Loeb CA, Hammad MAM, Barham DW, et al. · Sex Med Rev · 2024Review
- A novel on-demand therapy for lifelong premature ejaculation using a miniature transperineal electrical stimulator-the vPatch: an as-treated analysis.
Shechter A, Mondaini N, Serefoglu EC, et al. · J Sex Med · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Model of SNARE-mediated membrane adhesion kinetics.
Warner JM, Karatekin E, O'Shaughnessy B · PLoS One · 2009Research Support, U.S. Gov't, Non-P.H.S.
- [Application of C-QUR V-Patch system while performing preperitoneal alloplasty for small and middle umbilical hernias].
Vansovych VE, Kotik YM, Stroganov PV, et al. · Klin Khir · 2015English Abstract
- Infection and recurrence rates of the C-QUR V-Patchࡊ in ventral hernia repairs.
Cheng D, Bonato L, Leinkram C · Hernia · 2018Multicenter Study, Observational Study
- Outcomes of 157 V-Patch(TM) Implants in the Repair of Umbilical, Epigastric, and Incisional Hernias.
Keating JJ, Kennedy GT, Datta J, et al. · Am Surg · 2016Comparative Study
Other devices of this type
Also filed under product code QRC.
- in2 Smart (in2S)Virility Medical , Ltd. · 510(k) 2026
- MorMorari, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.